Radiotherapy, Temozolomide, and Bevacizumab Followed by Irinotecan, Temozolomide and Bevacizumab in Newly Diagnosed Glioblastoma Multiforme: Preliminary Results from an Ongoing Phase II Trial
Year: 2008
Type: article
Study design: Clinical Trial
Institution: Duke Medical Center
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2052928060
